Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy
Apply
Ipatasertib & Docetaxel
Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step